Control of severe predominantly eosinophilic asthma with the use of anti IL-5. Revista Alergia México, [S. l.], v. 70, n. 3, p. 199, 2023. DOI: 10.29262/ram.v70i3.1269. Disponível em: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/1269. Acesso em: 24 sep. 2026.